Parker-Hannifin Corporation announced a quarterly cash dividend of $2.00 per share, payable on December 4, 2026, to shareholders of record as of November 13, 2026. This marks the company's 306th consecutive quarterly dividend and continues its record of increasing annual dividends for 70 consecutive fiscal years, one of the longest streaks in the S&P 500. The dividend reflects Parker-Hannifin's strong financial health and commitment to returning value to shareholders. Investors can expect the company to maintain this dividend policy as it continues its leadership in motion and control technologies.
Parker-Hannifin Corporation's dividend announcement is context for readers following the Industrials sector. For readers following Industrials, here is Pluang's market snapshot as of Oct 29, 2026 03:21 WIB: Of 135 priced US Industrials stocks, 73 rose and 61 fell. Notable movers include PWR at USD 622.00 with a 1-day change of +7.46% and 100% buy order activity, CP at USD 84.82 down 6.92%, and TE at USD 2.63 up 6.91% with mixed order activity.
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
Vivid Seats Inc., a leading online ticket marketplace, will announce its financial results for the third quarter of 2026 on November 9, 2026, before the U.S. stock market opens. The company will host a webcast at 8:30 a.m. ET to discuss the results. ...
The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...
